372 related articles for article (PubMed ID: 21840657)
21. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
22. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
[TBL] [Abstract][Full Text] [Related]
23. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish postmenopausal women.
Agueda L; Bustamante M; Jurado S; Garcia-Giralt N; Ciria M; Saló G; Carreras R; Nogués X; Mellibovsky L; Díez-Pérez A; Grinberg D; Balcells S
J Bone Miner Res; 2008 Dec; 23(12):1954-63. PubMed ID: 18684085
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.
Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Tsatsoulis A
Maturitas; 2004 Jul; 48(3):259-64. PubMed ID: 15207892
[TBL] [Abstract][Full Text] [Related]
25. Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women.
Markatseli AE; Lazaros L; Markoula S; Kostoulas H; Sakaloglou P; Tigas S; Georgiou I; Tsatsoulis A
Clin Endocrinol (Oxf); 2014 Jul; 81(1):38-44. PubMed ID: 24621381
[TBL] [Abstract][Full Text] [Related]
26. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
27. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
28. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
29. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Theodoraki EV; Katsalira A; Dontas IA; Hammond N; Deloukas P; Lyritis GP
J Nutr Biochem; 2011 Aug; 22(8):752-7. PubMed ID: 21115334
[TBL] [Abstract][Full Text] [Related]
30. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
Mencej-Bedrač S; Zupan J; Mlakar SJ; Zavratnik A; Preželj J; Marc J
Drug Metabol Drug Interact; 2014; 29(2):111-4. PubMed ID: 24615483
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
Woo JH; Kim H; Kim JH; Kim JG
Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
[TBL] [Abstract][Full Text] [Related]
32. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
33. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women.
McClure L; Eccleshall TR; Gross C; Villa ML; Lin N; Ramaswamy V; Kohlmeier L; Kelsey JL; Marcus R; Feldman D
J Bone Miner Res; 1997 Feb; 12(2):234-40. PubMed ID: 9041055
[TBL] [Abstract][Full Text] [Related]
35. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta.
Vidal C; Brincat M; Xuereb Anastasi A
Maturitas; 2006 Mar; 53(4):386-95. PubMed ID: 16343827
[TBL] [Abstract][Full Text] [Related]
36. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J
Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419
[TBL] [Abstract][Full Text] [Related]
37. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
[TBL] [Abstract][Full Text] [Related]
38. Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.
Takács I; Lazáry A; Kósa JP; Kiss J; Balla B; Nagy Z; Bácsi K; Speer G; Lakatos P
Eur J Endocrinol; 2010 Feb; 162(2):423-31. PubMed ID: 19934266
[TBL] [Abstract][Full Text] [Related]
39. LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.
Zhou PR; Liu HJ; Liao EY; Zhang ZL; Chen DC; Liu J; Wu W; Xing XP; Xia WB; Xu L; Li M
Pharmacogenomics; 2014 Apr; 15(6):821-31. PubMed ID: 24897288
[TBL] [Abstract][Full Text] [Related]
40. RANKL/RANK/OPG system and bone status in females with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Szapska B; Wołkowska-Pokrywa K; Dyduch A
Bone; 2012 Jan; 50(1):156-60. PubMed ID: 22001124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
